Free Trial

Bank of Montreal Can Acquires 659,547 Shares of Relx Plc (NYSE:RELX)

Relx logo with Computer and Technology background
Remove Ads

Bank of Montreal Can boosted its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 290.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 886,758 shares of the technology company's stock after purchasing an additional 659,547 shares during the quarter. Bank of Montreal Can's holdings in Relx were worth $40,277,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. CENTRAL TRUST Co lifted its stake in Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after purchasing an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in shares of Relx during the 4th quarter worth $31,000. Sierra Ocean LLC acquired a new stake in Relx in the fourth quarter valued at about $43,000. Brown Brothers Harriman & Co. boosted its stake in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after buying an additional 662 shares in the last quarter. Finally, Private Trust Co. NA raised its stake in Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after acquiring an additional 199 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on RELX. StockNews.com downgraded shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Redburn Atlantic started coverage on Relx in a report on Wednesday, January 8th. They issued a "buy" rating for the company. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Finally, The Goldman Sachs Group initiated coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy".

Remove Ads

View Our Latest Analysis on RELX

Relx Trading Up 0.5 %

Shares of RELX traded up $0.26 during trading hours on Wednesday, hitting $51.77. 280,873 shares of the stock were exchanged, compared to its average volume of 663,217. Relx Plc has a fifty-two week low of $40.25 and a fifty-two week high of $51.99. The business has a 50-day moving average of $49.30 and a 200-day moving average of $47.91. The firm has a market capitalization of $95.81 billion, a P/E ratio of 27.83, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47.

Relx Increases Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be issued a dividend of $0.5586 per share. This is an increase from Relx's previous semi-annual dividend of $0.23. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. Relx's dividend payout ratio (DPR) is presently 59.68%.

Relx Company Profile

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Read More

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads